Kyverna Therapeutics Inc (KYTX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Dec 2023 | Mar 2024 | |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | |
| Operating Income | -21.38M | -29.36M | |
| Pre Tax Income | -20.67M | -26.69M | |
| Net Income | -20.67M | -26.69M | |
| Preferred Dividends | 0 | 0 | |
| Basic Earnings Per Share (EPS) | 0 | 0 | |
| EBIT | -21.41M | -29.38M | |
| EBITDA | -21.08M | -28.88M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.66M | 7.03M | 0 |
| Operating Income | -26.35M | -29.38M | -62.41M |
| Pre Tax Income | -26.35M | -28.89M | -60.37M |
| Net Income | -26.35M | -28.89M | -60.37M |
| Preferred Dividends | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -10.209 | -6.302 | -11.52 |
| EBIT | -26.35M | -29.39M | -62.46M |
| EBITDA | -25.76M | -28.58M | -61.51M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
